SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiaoping Xie, Shuang Geng, Hu Liu, Chaofan Li, Yuqin Yang, Bin Wang, Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8+ T cell, Human vaccines & immunotherapeutics, 2014, 10, 6

    CrossRef

  2. 2
    Yong Li, Huaxin Yang, Haiming Liao, Huihong Fan, Chenggang Liang, Lijuan Deng, Shaohong Jin, Simultaneous determination of ten biogenic amines in a thymopolypeptides injection using ultra-performance liquid chromatography coupled with electrospray ionization tandem quadrupole mass spectrometry, Journal of Chromatography B, 2013, 929, 33

    CrossRef

  3. 3
    Congwen Shao, Guojun Tian, Yuanjian Huang, Wenying Liang, Hang Zheng, Jiannan Wei, Cheng Wei, Cuilan Yang, Hong Wang, Weisen Zeng, Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration, International Immunopharmacology, 2013, 15, 3, 646

    CrossRef

  4. 4
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  5. 5
    Cynthia Tuthill, Israel Rios, Randy McBeath, Thymosin alpha 1: past clinical experience and future promise, Annals of the New York Academy of Sciences, 2010, 1194, 1
  6. 6
    Rong-Nan Chien, Yun-Fan Liaw, Current treatment of chronic HBV infection: An Asian-Pacific perspective, Current Hepatitis Reports, 2009, 8, 4, 154

    CrossRef

  7. 7
    Giselle Holness, Damaris C Carriero, Douglas T Dieterich, Hepatitis B therapies and antiviral resistance detection and management, Expert Review of Gastroenterology & Hepatology, 2009, 3, 6, 693

    CrossRef

  8. 8
    Arno Sungarian, Deus Cielo, Prakash Sampath, Nathaniel Bowling, Peter Moskal, Jack R. Wands, Suzanne M. de la Monte, Potential Role of Thymosin-1 Adjuvant Therapy for Glioblastoma, Journal of Oncology, 2009, 2009, 1

    CrossRef

  9. 9
    Yun-Fan Liaw, Nancy Leung, Jia-Horng Kao, Teerha Piratvisuth, Edward Gane, Kwang-Hyub Han, Richard Guan, George K. K. Lau, Stephen Locarnini, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update, Hepatology International, 2008, 2, 3, 263

    CrossRef

  10. 10
    Hyun Woong Lee, Joung Il Lee, Soon Ho Um, Sang Hoon Ahn, Hye Young Chang, Yong Kwang Park, Sun Pyo Hong, Young Myoung Moon, Kwang-Hyub Han, Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study, Journal of Gastroenterology and Hepatology, 2008, 23, 5
  11. 11
    Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang, Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis, Antiviral Research, 2008, 77, 2, 136

    CrossRef

  12. 12
    E. Loggi, A. Gramenzi, M. Margotti, C. Cursaro, S. Galli, G. Vitale, E. Grandini, A. Scuteri, R. Vukotic, P. Andreone, M. Bernardi, In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B, Journal of Viral Hepatitis, 2008, 15, 6
  13. 13
    Teerha Piratvisuth, Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B, Hepatology International, 2008, 2, 2, 140

    CrossRef

  14. 14
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  15. 15
    James Fung, Ching-Lung Lai, Man-Fung Yuen, Overcoming the problem of chronic hepatitis B, Drug Discovery Today: Therapeutic Strategies, 2006, 3, 2, 197

    CrossRef

  16. 16
    Jing You, Hong-Ying Cheng, Shou-Ming Yan, Yan-Wei Qiao, Jun-Hua Huang, Bao-Zhang Tang, Guo-Bing Wu, Jun-Yan Qu, Rong-Xue Wu, Lin Zhuang, Yong-Liang Ma, A Randomized, Controlled, Clinical Study of Thymosin Alpha-1 Versus Interferon-Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen, Journal of the Chinese Medical Association, 2005, 68, 2, 65

    CrossRef

  17. 17
    Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update, Liver International, 2005, 25, 3
  18. 18
    D. Sprengers, H.L.A. Janssen, Immunomodulatory therapy for chronic hepatitis B virus infection, Fundamental & Clinical Pharmacology, 2005, 19, 1
  19. 19
    S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins, The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial, Journal of Viral Hepatitis, 2005, 12, 3
  20. 20
    Daryl T.-Y. Lau, Fernando E. Membreno, Antiviral therapy for treatment-naı̈ve hepatitis B virus patients, Gastroenterology Clinics of North America, 2004, 33, 3, 581

    CrossRef

  21. 21
    Stephanos J Hadziyannis, George V Papatheodoridis, Emerging treatments in chronic hepatitis B, Expert Opinion on Emerging Drugs, 2004, 9, 2, 207

    CrossRef

  22. 22
    YUN-FAN LIAW, Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2004, 19, S6
  23. 23
    Rong-Nan Chien, Yun-Fan Liaw, Thymalfasin for the treatment of chronic hepatitis B, Expert Review of Anti-infective Therapy, 2004, 2, 1, 9

    CrossRef

  24. 24
    P. Andreone, A. Gramenzi, C. Cursaro, F. Felline, E. Loggi, A. D'Errico, M. Spinosa, S. Lorenzini, M. Biselli, M. Bernardi, Thymosin-α 1 plus interferon-α for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial, Journal of Viral Hepatitis, 2004, 11, 1
  25. 25
    Tarik Asselah, Corinne Castelnau, Nathalie Boyer, Marie-Pierre Ripault, Patrick Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2004, 28, 12, 1215

    CrossRef

  26. 26
    Anneke K Raney, Robert K Hamatake, Zhi Hong, Agents in clinical development for the treatment of chronic hepatitis B, Expert Opinion on Investigational Drugs, 2003, 12, 8, 1281

    CrossRef

  27. 27
    The EASL Jury, EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B, Journal of Hepatology, 2003, 39, 3

    CrossRef

  28. 28
    Pascal Lebray, Anaı̈s Vallet-Pichard, Marie-Louise Michel, Hélène Fontaine, Rodolphe Sobesky, Christian Bréchot, Stanislas Pol, Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection, Journal of Hepatology, 2003, 39, 151

    CrossRef

  29. 29
    Murat Saruc, Nuri Ozden, Nurten Turkel, Semin Ayhan, Lynette M. Hock, Isil Tuzcuoglu, Hakan Yuceyar, Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B, Journal of Pharmaceutical Sciences, 2003, 92, 7
  30. 30
    Hari S Conjeevaram, Anna Suk-Fong Lok, Management of chronic hepatitis B, Journal of Hepatology, 2003, 38, 90

    CrossRef

  31. 31
    Andy S Yu, Emmet B Keeffe, Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period, Clinics in Liver Disease, 2003, 7, 3, 551

    CrossRef

  32. 32
    Guido Gerken, Christoph Jochum, Viral Infections and Treatment, 2003,

    CrossRef

  33. 33
    Anastasia Rivkina, Sergey Rybalov, Chronic Hepatitis B: Current and Future Treatment Options, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002, 22, 6
  34. 34
    Y.-F. Liaw, Therapy of chronic hepatitis B: current challenges and opportunities, Journal of Viral Hepatitis, 2002, 9, 6
  35. 35
    Nancy Leung, Treatment of chronic hepatitis B: Case selection and duration of therapy, Journal of Gastroenterology and Hepatology, 2002, 17, 4
  36. 36
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,
  37. 37
    Hong Mei Wu, Jin-Ling Tang, Zhao Hui Sha, Youping Li, I Cao, Interventions for preventing infection in nephrotic syndrome, The Cochrane Library,
  38. 38
    Hong Mei Wu, Jin-Ling Tang, Li Cao, Zhao Hui Sha, Youping Li, Interventions for preventing infection in nephrotic syndrome, The Cochrane Library,
  39. 39
    Peng F Luo, Yu Ren, Ya-Lin Liu, Zhao-Fan Xia, Ulinastatin and thymosin as immune modulators for the treatment of sepsis, The Cochrane Library,